Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice.

Jeong SJ, Cooper JG, Ifergan I, McGuire TL, Xu D, Hunter Z, Sharma S, McCarthy D, Miller SD, Kessler JA

Open source

DOI
10.1016/j.nbd.2017.08.006
Published
2017 Dec
Container
Neurobiology of disease
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.nbd.2017.08.006,
  title = {Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice.},
  author = {Jeong SJ and Cooper JG and Ifergan I and McGuire TL and Xu D and Hunter Z and Sharma S and McCarthy D and Miller SD and Kessler JA},
  year = {2017},
  journal = {Neurobiology of disease},
  doi = {10.1016/j.nbd.2017.08.006},
  url = {https://doi.org/10.1016/j.nbd.2017.08.006}
}

RIS

TY  - JOUR
TI  - Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice.
AU  - Jeong SJ
AU  - Cooper JG
AU  - Ifergan I
AU  - McGuire TL
AU  - Xu D
AU  - Hunter Z
AU  - Sharma S
AU  - McCarthy D
AU  - Miller SD
AU  - Kessler JA
PY  - 2017
JO  - Neurobiology of disease
DO  - 10.1016/j.nbd.2017.08.006
UR  - https://doi.org/10.1016/j.nbd.2017.08.006
ER  - 

APA

SJ, J., JG, C., I, I., TL, M., D, X., Z, H., S, S., D, M., SD, M., & JA, K. (2017). Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice.. Neurobiology of disease. https://doi.org/10.1016/j.nbd.2017.08.006

Source records